John Fuller
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Diabetes Treatment and Management
- Ophthalmology top 0.5%
- Retinal Diseases and Treatments
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 12
- Diabetes Management and Research 12
- Diabetes Treatment and Management 6
-
- Cardiovascular Function and Risk Factors 6
- Blood Pressure and Hypertension Studies 4
- Co-authors
- Nish Chaturvedi (47 shared papers)Helen M. Colhoun (18 shared papers)Paul N. Durrington (10 shared papers)G. A. Hitman (10 shared papers)D. J. Betteridge (10 shared papers)Shona Livingstone (9 shared papers)H. A. W. Neil (9 shared papers)Valentine Charlton-Menys (5 shared papers)
- Journals
- Diabetes Care (32 papers)The Lancet (6 papers)Diabetologia (5 papers)Diabetes (4 papers)Cardiovascular Diabetology (3 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
John Fuller
103 papers receiving 11.2k citations
John Fuller's Hit Papers
Peers
Comparison fields: 5 of 149
- Endocrinology, Diabetes and Metabolism 3.9k
- Ophthalmology 977
- Cardiology and Cardiovascular Medicine 2.0k
- Nephrology 596
- Clinical Biochemistry 568
Countries citing papers authored by John Fuller
This map shows the geographic impact of John Fuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Fuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Fuller more than expected).
Fields of papers citing papers by John Fuller
This network shows the impact of papers produced by John Fuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Fuller. The network helps show where John Fuller may publish in the future.
Co-authors
The 25 scholars most cited alongside John Fuller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial Hit paper breakdown → | 2004 | 2855 |
| 2 | Vascular Risk Factors and Diabetic Neuropathy Hit paper breakdown → | 2005 | 1030 |
| 3 | Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes Hit paper breakdown → | 1998 | 586 |
| 4 | 2008 | 347 | |
| 5 | 1983 | 340 | |
| 6 | 2008 | 338 | |
| 7 | 2001 | 309 | |
| 8 | 2006 | 303 | |
| 9 | 1998 | 262 | |
| 10 | beta-Catenin regulates vascular endothelial growth factor expression in colon cancer. | 2003 | 249 |
| 11 | 2004 | 204 | |
| 12 | 2009 | 201 | |
| 13 | 2003 | 191 | |
| 14 | 2008 | 186 | |
| 15 | 2001 | 156 | |
| 16 | 2005 | 149 | |
| 17 | 1998 | 144 | |
| 18 | 2011 | 140 | |
| 19 | 2001 | 137 | |
| 20 | 2002 | 134 |
About John Fuller
John Fuller is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Molecular Biology, Surgery and Physiology, having authored 109 papers that have together received 11.9k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers), Diabetes Management and Research (12 papers), Lipoproteins and Cardiovascular Health (9 papers), Diabetes Treatment and Management (6 papers), Cardiovascular Function and Risk Factors (6 papers), Chronic Kidney Disease and Diabetes (5 papers), Retinal Diseases and Treatments (5 papers) and Blood Pressure and Hypertension Studies (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.9k citations), Ophthalmology (977 citations), Cardiology and Cardiovascular Medicine (2.0k citations), Nephrology (596 citations) and Clinical Biochemistry (568 citations). John Fuller has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Nish Chaturvedi, Helen M. Colhoun, Paul N. Durrington, G. A. Hitman, D. J. Betteridge, Shona Livingstone, H. A. W. Neil, Valentine Charlton-Menys, Margaret J. Thomason and Michael I. Mackness. Their work appears in journals such as Diabetes Care, The Lancet, Diabetologia, Diabetes and Cardiovascular Diabetology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.